UCB And 4 Other Stocks Have Very High Payout Ratio

(VIANEWS) – NN GROUP (NN.AS), UCB (UCB.BR), HAFNIA LIMITED (HAFNI.OL) are the highest payout ratio stocks on this list.

We have gathered information regarding stocks with the highest payout ratio up until now. The payout ratio in itself isn’t a guarantee of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.

When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.

1. NN GROUP (NN.AS)

181.56% Payout Ratio

NN Group N.V., a financial services company, provides life and non-life insurance products in the Netherlands and internationally. The company operates through Netherlands Life, Netherlands Non-life, Insurance Europe, Japan Life, Banking, and Other segments. It offers Life insurance products, such as group and individual pension products, retail life insurance, and corporate life products; and non-life insurance products, including motor, fire, liability, transport, travel, health, property and casualty, and disability and accident insurance products. The company also provides banking services, including mortgage loans, savings accounts, bank annuities, consumer lending, and retail investment products, as well as administration and management services; reinsurance services; and retirement products and services. It offers its products to individuals, small and medium-sized enterprises, and Corporates customers directly through tied agents, agents/ brokers, platform insurance, and direct channels. The company was formerly known as ING Insurance Topholding N.V. and changed its name to NN Group N.V. in March 2014. NN Group N.V. was founded in 1845 and is headquartered in the Hague, the Netherlands.

Earnings Per Share

As for profitability, NN GROUP has a trailing twelve months EPS of €1.41.

PE Ratio

NN GROUP has a trailing twelve months price to earnings ratio of 24.74. Meaning, the purchaser of the share is investing €24.74 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.81%.

Moving Average

NN GROUP’s worth is higher than its 50-day moving average of €33.75 and under its 200-day moving average of €37.39.

Volume

Today’s last reported volume for NN GROUP is 445812 which is 59.82% below its average volume of 1109580.

Yearly Top and Bottom Value

NN GROUP’s stock is valued at €34.88 at 22:10 EST, way below its 52-week high of €47.63 and way above its 52-week low of €31.63.

More news about NN GROUP.

2. UCB (UCB.BR)

60.47% Payout Ratio

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; BIMZELX for treating psoriasis, psoriatic arthritis, axial spondyloarthritis, and hidradenitis suppurativa; and dapirolizumab pegol for systemic lupus erythematosus. In addition, the company is involved in developing rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; zilucoplan to treat myasthenia gravis and immune-mediated necrotizing myopathy; staccato alprazolam to treat tereotypical prolonged seizure; Bepranemab to treat Alzheimer's disease; and UCB0599 to treat Parkinson's disease. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, Otsuka, and doc.ai. It operates in the United States, Japan, Germany, rest of Europe, Spain, France, China, Italy, the United Kingdom, Ireland, Belgium, and internationally. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.

Earnings Per Share

As for profitability, UCB has a trailing twelve months EPS of €2.15.

PE Ratio

UCB has a trailing twelve months price to earnings ratio of 37.9. Meaning, the purchaser of the share is investing €37.9 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.81%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Apr 28, 2023, the estimated forward annual dividend rate is 1.33 and the estimated forward annual dividend yield is 1.62%.

Moving Average

UCB’s value is below its 50-day moving average of €82.51 and higher than its 200-day moving average of €79.29.

More news about UCB.

3. HAFNIA LIMITED (HAFNI.OL)

40.35% Payout Ratio

Hafnia Limited owns and operates oil product tankers. It operates through Long Range II, Long Range I, Medium Range (MR), Handy size, Chemical-Handy, and Chemical-MR segments. The company transports petroleum oil products, vegetable oil, and easy chemicals to national and international oil companies, and chemical companies, as well as trading and utility companies. It provides ship owning, ship-management, chartering, investment, and agency office services. The company is based in Hamilton, Bermuda.

Earnings Per Share

As for profitability, HAFNIA LIMITED has a trailing twelve months EPS of kr20.09.

PE Ratio

HAFNIA LIMITED has a trailing twelve months price to earnings ratio of 2.6. Meaning, the purchaser of the share is investing kr2.6 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 56.56%.

Sales Growth

HAFNIA LIMITED’s sales growth is negative 90.5% for the present quarter and negative 93.9% for the next.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 91.4% and a negative 96.8%, respectively.

Volume

Today’s last reported volume for HAFNIA LIMITED is 127845 which is 87.61% below its average volume of 1032520.

More news about HAFNIA LIMITED.

4. FLOW TRADERS (FLOW.AS)

38.04% Payout Ratio

Flow Traders Ltd. operates as a financial technology-enabled multi-asset class liquidity provider in Europe, the Americas, and Asia. The company provides liquidity support that allows investors to continue to buy or sell exchange traded products or other financial instruments. It offers liquidity through on screen, which is conducted on stock exchanges; and off exchange through request for quote platforms. The company was founded in 2004 and is headquartered in Amsterdam, the Netherlands.

Earnings Per Share

As for profitability, FLOW TRADERS has a trailing twelve months EPS of €2.76.

PE Ratio

FLOW TRADERS has a trailing twelve months price to earnings ratio of 7.15. Meaning, the purchaser of the share is investing €7.15 for every euro of annual earnings.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Apr 28, 2023, the estimated forward annual dividend rate is 1.6 and the estimated forward annual dividend yield is 8.19%.

More news about FLOW TRADERS.

5. TIKEHAU CAPITAL (TKO.PA)

33.71% Payout Ratio

Tikehau Capital is a private equity and venture capital firm specializing in providing a full range of financing products including senior secured loans, equity, senior debt, unitranche, mezzanine, and preferred shares. The firm seeks to make early stage, mezzanine, and turnaround investments and manage long-term capital for institutional and private investors in various asset classes including credit, listed, private equity, and real estate. It invests in all sectors and all countries with a focus on Singapore. The firm prefers to invest between €0.41 million ($0.5 million) and €70 million ($82.1073 million). The firm seeks to invest in small and middle market European corporate. It makes balance sheet investments. Tikehau Capital was founded in June 2004 and is based in Paris, France with additional offices across Middle East, Europe, North America and Asia.

Earnings Per Share

As for profitability, TIKEHAU CAPITAL has a trailing twelve months EPS of €1.78.

PE Ratio

TIKEHAU CAPITAL has a trailing twelve months price to earnings ratio of 13.12. Meaning, the purchaser of the share is investing €13.12 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.34%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on May 18, 2023, the estimated forward annual dividend rate is 0.7 and the estimated forward annual dividend yield is 3.12%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 50%, now sitting on 602.38M for the twelve trailing months.

More news about TIKEHAU CAPITAL.

Leave a Reply

Your email address will not be published. Required fields are marked *